Comparison between Variable and Conventional Volume-Controlled Ventilation on Cardiorespiratory Parameters in Experimental Emphysema by Isabela Henriques et al.
ORIGINAL RESEARCH
published: 30 June 2016
doi: 10.3389/fphys.2016.00277
Frontiers in Physiology | www.frontiersin.org 1 June 2016 | Volume 7 | Article 277
Edited by:
Reinoud Gosens,
University of Groningen, Netherlands
Reviewed by:
Deepak A. Deshpande,
Thomas Jefferson University, USA
Elke Vlemincx,
Belgian National Fund for Scientific
Research - Research Foundation
Flanders, Belgium
*Correspondence:
Patricia R. M. Rocco
prmrocco@gmail.com
†
These authors have contributed
equally to this work.
Specialty section:
This article was submitted to
Respiratory Physiology,
a section of the journal
Frontiers in Physiology
Received: 08 April 2016
Accepted: 20 June 2016
Published: 30 June 2016
Citation:
Henriques I, Padilha GA, Huhle R,
Wierzchon C, Miranda PJB, Ramos IP,
Rocha N, Cruz FF, Santos RS, de
Oliveira MV, Souza SA,
Goldenberg RC, Luiz RR, Pelosi P, de
Abreu MG, Silva PL and Rocco PRM
(2016) Comparison between Variable
and Conventional Volume-Controlled
Ventilation on Cardiorespiratory
Parameters in Experimental
Emphysema. Front. Physiol. 7:277.
doi: 10.3389/fphys.2016.00277
Comparison between Variable and
Conventional Volume-Controlled
Ventilation on Cardiorespiratory
Parameters in Experimental
Emphysema
Isabela Henriques 1†, Gisele A. Padilha 1 †, Robert Huhle 2 †, Caio Wierzchon 1,
Paulo J. B. Miranda 1, Isalira P. Ramos 3, 4, Nazareth Rocha 1, 5, Fernanda F. Cruz 1,
Raquel S. Santos 1, Milena V. de Oliveira 1, Sergio A. Souza 4, 6, Regina C. Goldenberg 3,
Ronir R. Luiz 7, Paolo Pelosi 8, Marcelo G. de Abreu 2, Pedro L. Silva 1 and
Patricia R. M. Rocco 1*
1 Laboratory of Pulmonary Investigation, Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de
Janeiro, Brazil, 2 Pulmonary Engineering Group, Department of Anesthesiology and Intensive Care Therapy, University
Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany, 3 Laboratory of Molecular and Cellular
Cardiology, Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, 4National
Center for Structural Biology and Bioimaging, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, 5Department of
Physiology and Pharmacology, Biomedical Institute, Fluminense Federal University, Niterói, Brazil, 6Nuclear Medicine Service,
Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, 7 Institute of Public
Health Studies, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, 8Department of Surgical Sciences and Integrated
Diagnostics, IRCCS AOU San Martino IST, University of Genoa, Genoa, Italy
Emphysema is characterized by loss of lung tissue elasticity and destruction of structures
supporting alveoli and capillaries. The impact of mechanical ventilation strategies on
ventilator-induced lung injury (VILI) in emphysema is poorly defined. New ventilator
strategies should be developed to minimize VILI in emphysema. The present study was
divided into two protocols: (1) characterization of an elastase-induced emphysemamodel
in rats and identification of the time point of greatest cardiorespiratory impairment, defined
as a high specific lung elastance associated with large right ventricular end-diastolic
area; and (2) comparison between variable (VV) and conventional volume-controlled
ventilation (VCV) on lung mechanics and morphometry, biological markers, and cardiac
function at that time point. In the first protocol, Wistar rats (n = 62) received
saline (SAL) or porcine pancreatic elastase (ELA) intratracheally once weekly for 4
weeks, respectively. Evaluations were performed 1, 3, 5, or 8 weeks after the last
intratracheal instillation of saline or elastase. After identifying the time point of greatest
cardiorespiratory impairment, an additional 32 Wistar rats were randomized into the
SAL and ELA groups and then ventilated with VV or VCV (n = 8/group) [tidal volume
(VT) = 6mL/kg, positive end-expiratory pressure (PEEP) = 3 cmH2O, fraction of inspired
oxygen (FiO2)= 0.4] for 2 h. VV was applied on a breath-to-breath basis as a sequence of
randomly generated VT values (mean VT = 6mL/kg), with a 30% coefficient of variation.
Non-ventilated (NV) SAL and ELA animals were used for molecular biology analysis. The
time point of greatest cardiorespiratory impairment, was observed 5 weeks after the
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last elastase instillation. At this time point, interleukin (IL)-6, cytokine-induced neutrophil
chemoattractant (CINC)-1, amphiregulin, angiopoietin (Ang)-2, and vascular endothelial
growth factor (VEGF) mRNA levels were higher in ELA compared to SAL. In ELA animals,
VV reduced respiratory system elastance, alveolar collapse, and hyperinflation compared
to VCV, without significant differences in gas exchange, but increased right ventricular
diastolic area. Interleukin-6 mRNA expression was higher in VCV and VV than NV, while
surfactant protein-D was increased in VV compared to NV. In conclusion, VV improved
lung function and morphology and reduced VILI, but impaired right cardiac function in
this model of elastase induced-emphysema.
Keywords: echocardiography, elastic fiber, surfactant protein-D, elastance, alveolar hyperinflation
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is characterized
by persistent airflow limitation due to an enhanced chronic
inflammatory response (GOLD, 20151), and can lead to
respiratory failure and the need for ventilator support (MacIntyre
and Huang, 2008). Although the use of noninvasive positive-
pressure ventilation for COPD is increasingly popular and
associated with shorter length of hospital stay, lower mortality
rates, and lower costs, severe cases still require invasive
mechanical ventilation (Stefan et al., 2015a,b). In patients
with COPD, invasive volume-controlled (VCV) or pressure-
controlled mechanical ventilation may exacerbate preexisting
lung damage as a result of time-constant inhomogeneity,
which predisposes to delayed inflation of some lung areas and
overdistension of other regions (Laghi et al., 2001; MacIntyre
and Huang, 2008); this, in turn, may lead to ventilator-induced
lung injury (VILI) and a negative impact on right ventricular
function (Vieillard-Baron et al., 1999; Wrobel et al., 2015).
Therefore, a mechanical ventilation strategy able to promote a
more homogeneous distribution of aeration without affecting
cardiac function could be a useful therapeutic option for
patients with COPD. Variable ventilation (VV) can improve
surfactant production (Arold et al., 2009), maintain airway
patency (Suki et al., 1994), and reduce cyclic closing/reopening,
thus decreasing shear stress, inflammation, and epithelial cell
damage (Thammanomai et al., 2013). In addition, VV promotes
lung functional benefits in experimental acute respiratory distress
syndrome (ARDS) (Spieth et al., 2009b; Ruth Graham et al.,
2011), severe bronchospasm (Mutch et al., 2007), and prolonged
anesthesia (Mutch et al., 2000).
The effects of mechanical ventilation on VILI in patients with
COPD were derived from pre-clinical and clinical studies in
ARDS. To date, however, no study has evaluated the impact of
VCV and VV on VILI in experimental or clinical emphysema.
Since emphysema is characterized by loss of lung tissue
elasticity and destruction of structures supporting alveoli
and capillaries, we hypothesized that VV might reduce lung
hyperinflation and atelectasis, thus improving pulmonary
1Global Initiative for Obstructive Lung Disease. Global Strategy for the Diagnosis,
Management and Prevention of COPD, Global Initiative for Chronic Obstructive
Lung Disease (GOLD) 2015. Available online at: http://www.goldcopd.org/
function, with less epithelial and endothelial cell damage and
inflammation. The present study was divided into two protocols:
(1) characterization of an elastase-induced emphysema model
in rats, with identification of the time point of greatest
cardiorespiratory impairment, defined as a high specific lung
elastance associated with large right ventricular end-diastolic
area; and (2) comparison, at that time point, of the effects of
VV vs. VCV on gas exchange, lung mechanics and histology,
right ventricular function, biological markers associated with
inflammation, damage inflicted to alveolar epithelial and
endothelial cells, and alveolar stretch.
MATERIALS AND METHODS
This study was approved by the Ethics Committee of the Health
Sciences Center, Federal University of Rio de Janeiro. All animals
received humane care in compliance with the Principles of
Laboratory Animal Care formulated by the National Society for
Medical Research and the U.S. National Academy of Sciences
Guide for the Care and Use of Laboratory Animals.
Animal Preparation and Experimental
Protocol
First Protocol: Characterization of Elastase-Induced
Emphysema Model
Sixty-twoWistar rats were randomly assigned across two groups:
SAL and ELA. In ELA group, rats received porcine pancreatic
elastase (2 IU in 0.1ml of saline solution, Sigma Chemical Co.,
St. Louis, MO, USA) intratracheally, once weekly for 4 weeks.
SAL animals received saline solution only via the same route and
dosage schedule. Before each intratracheal instillation, animals
were premedicated with intraperitoneal diazepam (10mg/kg,
Compaz R©, Cristália, Itapira, SP, Brazil) and anesthetized with
1.5–2.0% isoflurane (Cristália, SP, Brazil) by mask.
Evaluations were performed 1, 3, 5, or 8 weeks after the
last intratracheal instillation of saline or porcine pancreatic
elastase (Figure S1). Briefly, animals were anesthetized with
intraperitoneal diazepam (10mg/kg, Compaz R©, Cristália,
Itapira, SP, Brazil), ketamine (50–100mg/kg, Ketamin-S+ R©,
Cristália, Itapira, SP, Brazil), and midazolam (2mg/kg,
Dormicum R©, União Química, São Paulo, SP, Brazil),
tracheotomized, paralyzed with pancuronium bromide (2mg/kg
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i.v., Cristália, Itapira, SP, Brazil), and mechanically ventilated
(Servo-i, MAQUET, Solna, Sweden) in VCV mode, using
the following parameters: tidal volume (VT) = 6mL/kg,
respiratory rate (RR) = 80 breaths/min, fraction of inspired
oxygen (FiO2) = 0.4, and positive end-expiratory pressure
(PEEP) = 3 cmH2O. During ventilation, intravenous fluids
were administered to maintain a mean arterial pressure
(MAP) ≥70mmHg and midazolam plus ketamine were
administered to maintain sedation. Fifty-six rats were used to
evaluate lung mechanics and morphometry, end-expiratory
lung volume (EELV), biological markers associated with
inflammation (interleukin [IL]-6, cytokine-induced neutrophil
chemoattractant [CINC]−1), alveolar stretch (amphiregulin),
type II epithelial cell mechanotransduction (surfactant protein
[SP]-D), and endothelial cell damage (angiopoietin [Ang]-2
and vascular endothelial growth factor [VEGF]), as well as
echocardiographic parameters (n = 7 at each time point in SAL
and ELA groups). In six animals (n = 3/group), a computed
tomography scan of the lungs was performed at 5 weeks.
Second Protocol: Comparison between Variable and
Conventional Volume-Controlled Ventilation
After identifying the time point of greatest cardiorespiratory
impairment, an additional 32 Wistar rats were randomized into
the SAL and ELA groups, as previously described. Animals
were premedicated and anesthetized as described for the first
protocol. An intravenous catheter (Jelco 24G) was inserted into
the tail vein for continuous infusion of midazolam (2mg/kg/h),
ketamine (50mg/kg/h), and Ringer’s lactate (7mL/kg/h, B.
Braun, Crissier, Switzerland). Anesthetized animals were kept
in the dorsal recumbent position and tracheotomized via
a midline neck incision after subcutaneous injection of 2%
lidocaine (Cristália, Itapira, SP, Brazil). The right internal
carotid artery was cannulated (18 G, Arrow International,
USA) for blood sampling and MAP measurement. Heart
rate (HR), MAP, and rectal temperature were continuously
recorded (Networked Multiparameter Veterinary Monitor
LifeWindow 6000V, Digicare Animal Health, Florida, USA).
Body temperature was maintained at 37.5 ± 1◦C using a
heating bed. Gelafundin R© (B. Braun, São Gonçalo, RJ, Brazil)
was administered intravenously in 0.5-mL increments to keep
MAP ≥ 70mmHg. Animals were paralyzed by intravenous
administration of pancuronium bromide (2mg/kg, Cristália,
Itapira, SP, Brazil) and mechanically ventilated (Inspira, Harvard
Apparatus, Holliston, Massachusetts, USA) in VCV mode
with VT = 6mL/kg, RR adjusted to maintain arterial pHa
in the 7.35–7.45 range, Fio2 = 0.4, and zero end-expiratory
pressure (ZEEP). After hemodynamic stabilization, respiratory
system mechanics, and arterial blood gases (Radiometer ABL80
FLEX, Copenhagen NV, Denmark) were measured (Baseline
ZEEP). PEEP was then increased to 3 cmH2O and, after
5min, respiratory system mechanics, arterial blood gases, and
echocardiographic parameters were analyzed (Baseline PEEP).
Following this step, SAL and ELA animals were randomized
to VV or VCV (n = 8/group). VV was applied on a breath-
to-breath basis as a sequence of randomly generated VT values
(Gaussian distribution, n = 1200; mean VT = 6mL/kg), with a
30% coefficient of variation (nVentInspira, Dresden, Germany),
for 2 h (Huhle et al., 2014). At the end of the experiment,
echocardiographic parameters, respiratory system mechanics,
and arterial blood gases were analyzed at each ventilator setting.
Animals were then euthanized via overdose of intravenous
sodium thiopental (50mg/kg, Cristália, Itapira, SP, Brazil) and
their lungs extracted at PEEP = 3 cmH2O for measurement of
EELV, as well as lung histological and molecular biology analyses
(Figure S2).
Echocardiography
First Protocol
Echocardiographic measurements were obtained at baseline and
1, 3, 5, and 8 weeks after the last intratracheal instillation of SAL
or PPE. Right ventricular (RV) end-diastolic area, pulmonary
artery acceleration time (PAT), pulmonary artery ejection time
(PET), and their ratio (PAT/PET) were used as indirect indexes
of pulmonary arterial hypertension.
Second Protocol
Echocardiographic parameters were measured before and 2 h
after mechanical ventilation (VV or VCV) in the SAL and ELA
groups. In addition to the aforementioned parameters associated
with right ventricular impairment, left ventricle diastolic area,
ejection fraction, and fractional shortening were computed, as
mechanical ventilation may also affect left systolic function.
Technique
Animals were placed in the dorsal recumbent position and the
precordial region was shaved. Transthoracic echocardiography
was performed by an expert (NR), using a 10-MHz probe (Esaote
model, CarisPlus, Firenze, Italy). Images were obtained from
the subcostal and parasternal views. Short-axis two-dimensional
views of the left and right ventricles were acquired at the level
of the left ventricular papillary muscles to measure left and right
ventricular end-diastolic area (LV and RV area, respectively).
The left ventricular ejection fraction and fractional shortening
were calculated in one-dimensional mode analysis of the left
ventricle guided by the parasternal short-axis view. Pulsed-wave
Doppler was used to measure PAT, PET, and the PAT/PET ratio.
The diameter of the right atrium and inferior vena cava were
assessed from the subcostal view. Measurements were obtained
in accordance with American Society of Echocardiography
Guidelines (Thibault et al., 2010; Lang et al., 2015).
Computed Tomography
First Protocol
Computed tomography (CT) scans were performed to evaluate
the presence of emphysematous areas. CT was performed in SAL
and ELA animals at the time point of greatest cardiorespiratory
impairment (5 weeks after the last elastase administration) with
an Optima 560 PET/CT scanner (GE Healthcare, Boston, USA).
The acquisition protocol was based on helical CT with axial slices
of 0.625mm (16 × 0.625mm) thickness and 48 images, with a
beam collimation of 10.0mm and a DFOV of 10 cm. The X-ray
tube was set to 120 kV and 80mA. The total time for each scan
was 12 s. Hounsfield units (HU) were analyzed in both lungs, at
the bifurcation of pulmonary arteries, in the Onis 2.5 software
environment (DigitalCore, Co. Ltd., Tokyo, Japan).
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Lung Mechanics
First Protocol
Airflow, volume, and airway and esophageal pressures were
measured (Riva et al., 2008), and lung mechanics were analyzed
by the end-inflation occlusion method (Bates et al., 1985). Static
lung elastance (Est,L) was calculated by dividing the difference
between respiratory system and chest wall elastic pressure (Pel,L)
by VT. Since EELV may change due to emphysema, Est,L was
normalized by EELV, which is equal to specific lung elastance
(EL,spec).
Second Protocol
Airflow, volume, and airway pressure were continuously
recorded. Elastance (E,RS) and resistance (R,RS) were calculated
based on the equation of motion (Uhlig et al., 2014).
Volume-independent elastance (E1,RS) and volume-dependent
elastance (E2,RS) were calculated on a cycle-by-cycle basis
(Carvalho et al., 2013). The partition model of respiratory
system elastance allows calculation of the E,RS non-linearity
index (%E2), which quantifies the concavity of the dynamic
pressure-volume (PV) curve, thus enabling identification of
tidal recruitment/overdistension, which can be present in this
emphysema model.
Technique
All parameters were recorded with a computer running
custom software written in LabVIEW R© (National Instruments;
Austin, Texas, USA) (Silva et al., 2013). All signals were
amplified in a three-channel signal conditioner (TAM-D HSE
Plugsys Transducers Amplifiers, Module Type 705/2, Harvard
Apparatus, Holliston, Massachusetts, USA) and sampled at
200Hz with a 12-bit analog-to-digital converter (National
Instruments; Austin, Texas, USA).
End-Expiratory Lung Volume Measurement
First and Second Protocols
EELV was determined as previously described (Scherle, 1970)
to identify the resulting lung volume at end-expiration, as
emphysema is characterized by destruction of alveolar septa
with hyperinflated areas. Briefly, a jar containing sufficient saline
solution with a surplus weight submerged was placed on a
common laboratory scale, which was subsequently tared to zero.
The lungs were fixed to a laboratory stand by means of a thread
with the surplus weight and completely submerged in the saline
solution. The liquid displaced by the submerged lungs adds
correspondingly to the weight on the scale. Because the specific
gravity of saline differs no more than 2–3% from 1 g/cm3, the
volume of the organ may be expressed directly by the weight gain
registered on the scale.
Histology
First Protocol
Lung morphometry was analyzed in SAL and ELA animals to
characterize the model of emphysema.
Second Protocol
Lung morphometry was evaluated in animals ventilated with
VCV and VV, as well as in non-ventilated (NV) animals (SAL
and ELA), to analyze the impact of different ventilator strategies
on lung parenchyma.
Technique
Morphometric analysis was performed in lungs excised at end-
expiration (PEEP = 3 cmH2O). Immediately after removal, the
left lung was flash-frozen by immersion in liquid nitrogen, fixed
with Carnoy’s solution, and paraffin-embedded. Sections (4µm
thick) were cut and stained with hematoxylin-eosin. Investigators
(CW and VLC) blinded to the origin of the material performed
the microscopic examination. Morphometric analysis was done
using an integrating eyepiece with a coherent system made
of a 100-point grid consisting of 50 lines of known length,
coupled to a conventional light microscope (Axioplan, Zeiss,
Oberkochen, Germany). The volume fraction of collapsed and
normal pulmonary areas and the fraction of the lung occupied by
large-volume gas-exchanging air spaces (hyperinflated structures
with a morphology distinct from that of alveoli and wider
than 120µm) were determined by the point-counting technique
(Weibel, 1990), at a magnification of ×200 across 10 random,
noncoincident microscopic fields. Briefly, points falling on
collapsed or normal pulmonary areas or hyperinflated alveoli
were counted and divided by the total number of points in
each microscopic field. Lung tissue distortion was assessed by
measuring the mean linear intercept between alveolar walls
(Lm) at a magnification of ×400 (Weibel, 1990). In the first
protocol, collagen and elastic fibers (stained with the Picrosirius-
polarization method and Weigert’s resorcin fuchsin modified
with oxidation, respectively) were quantified in alveolar septa at
×400 magnification (Antunes et al., 2014). The area occupied by
fibers was determined by digital densitometric recognition in the
Image-Pro Plus 7.1 for Windows software environment (Media
Cybernetics, Silver Spring, MD, USA) and divided by the area
of each studied septum. Results were expressed as the fractional
area occupied by elastic and collagen fibers in the alveolar septa.
Bronchi and blood vessels were excluded from themeasurements.
Molecular Biology
First and Second Protocols
Quantitative real-time reverse transcription polymerase chain
reaction (RT-PCR) was performed to assess IL-6, CINC-
1, amphiregulin, SP-D, Ang-2, and VEGF. In the first
protocol, these analyses were performed at the time point
of greatest cardiorespiratory impairment. Central slices of
the right lung were cut, collected in cryotubes, flash-frozen
by immersion in liquid nitrogen, and stored at −80◦C.
Total RNA was extracted from frozen tissues using the
RNeasy Plus Mini Kit (Qiagen, Hilden, Germany) following
the manufacturer’s recommendations. RNA concentration was
measured by spectrophotometry in a Nanodrop ND-1000 system
(ThermoScientific, Wilmington, DE, USA). First-strand cDNA
was synthesized from total RNA using a Quantitec reverse
transcription kit (Qiagen, Hilden, Germany). The primers used
are described in the online supplement (Table S1). Relative
mRNA levels were measured with a SYBR green detection
system in ABI 7500 real-time PCR (Applied Biosystems, Foster
City, California, USA). Samples were run in triplicate. For
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each sample, the expression of each gene was normalized to
the acidic ribosomal phosphoprotein P0 (36B4) housekeeping
gene and expressed as fold changes relative to SAL animals
(first protocol) or to non-ventilated (NV) animals (SAL
and ELA—second protocol), using the 2−11Ct method, where
1Ct= Ctreference gene − Cttarget gene.
Statistical Analysis
The number of animals per group was based on pilot studies of
the elastase instillation model of emphysema. A sample size of
eight animals per group (providing for one animal as dropout)
would provide the appropriate power (1 − β = 0.8) to identify
significant (α = 0.05) differences in dynamic respiratory system
elastance between VCV and VV, taking into account an effect size
d = 1.57, a two-sided test, and a sample size ratio = 1 (G∗Power
3.1.9.2, University of Düsseldorf, Germany).
In the first protocol, one-way ANOVA followed by
Bonferroni’s post-hoc test was used to evaluate differences
among SAL or ELA group at different time points. As no
significant differences were observed among SAL groups at each
time point, all data were into a single SAL group. At each time
point, SAL was compared to ELA using Student’s t-test followed
by Bonferroni adjustment, with α adjusted to four comparisons
(0.05/4= 0.0125).
In the second protocol, a paired t-test was used to compare
data between Baseline PEEP and End. Two-way repeated-
measures ANOVA followed by Bonferroni’s post-hoc test was
used to compare cardiorespiratory function parameters between
SAL and ELA groups ventilated with VV and VCV. One-
way ANOVA followed by Bonferroni’s post-hoc test was used
to compare lung morphometry between NV, VV, and VCV
in the SAL and ELA groups. Molecular biology analyses were
performed using the Kruskal–Wallis test followed by Dunn’s
multiple comparison test within the SAL (NV, VV, VCV) and
ELA (NV, VV, VCV) groups. Parametric data were expressed
as mean ± standard deviation (SD) and nonparametric data as
median (interquartile range). All tests were performed using the
GraphPad Prism v6.07 statistical software package (GraphPad
Software, La Jolla, California, USA).
RESULTS
First Protocol: Characterization of
Elastase-Induced Emphysema in Rats
Figure 1 depicts the time course of EELV, EL,spec, Lm, fraction
area of hyperinflated alveoli (hyperinflation), percentage of
elastic and collagen fibers, PAT/PET ratio, and RV area in
the ELA group. Even though lung mechanics and collagen
fiber content tended to return to SAL values, hyperinflation
and Lm remained higher than in SAL animals, associated
with elastolysis. Additionally, a continuous deterioration of
cardiovascular function was observed, reaching significance 3–5
weeks after the last dose of elastase, with no subsequent recovery.
The time point of greatest cardiorespiratory impairment, defined
as a high EL,spec associated with large RV area, was observed
5 weeks after the last elastase instillation. At this time point,
mRNA expressions of IL-6 [median (interquartile range): ELA,
5.33 (0.82–12.89) vs. SAL, 0.64 (0.62–0.88)], CINC-1 [ELA,
1.79 (1.28–5.92) vs. SAL, 0.83 (0.42–1.21)], amphiregulin [ELA,
7.18 (4.82–10.27) vs. SAL, 0.94 (0.36–3.90)], Ang-2 [ELA, 2.72
(2.08–3.15) vs. SAL, 0.81 (0.38–1.23)], and VEGF [ELA, 3.47
(2.14–5.16) vs. SAL, 0.95 (0.76–1.24)] were higher in ELA
compared to SAL, with no significant changes in SP-D expression
(Figure 2). Figure S3 depicts CT images from SAL and ELA
groups. SAL animals showed densities from −543 to −496 HU
and −608 to −525 HU for the right and left lungs, respectively.
On the other hand, ELA animals showed densities from −914
to −466 HU and −929 to −842 HU for the right and left lungs,
respectively.
Second Protocol: Comparison between
Variable and Conventional
Volume-Controlled Ventilation
MAP decreased over time in SAL and ELA animals alike and
was lower in VV compared to VCV, but remained ≥ 70mmHg
(Figure S4). At Baseline ZEEP, respiratory variables and arterial
blood gases did not differ among groups (Table S2).
Table 1 shows respiratory and gas-exchange variables at
Baseline PEEP and End. VT, V’E, PEEP, and intrinsic positive
end-expiratory pressure (PEEPi) levels were comparable among
groups, whereas the coefficient of variation in VT was higher
in VV compared to VCV (VV: 28.0 ± 2.1 vs. VCV: 2.2 ± 0.9,
p < 0.0001). At End, E,RS was lower in VV than VCV in both
the SAL and ELA groups (VV: 2.5 ± 0.4 vs. VCV: 3.6 ± 0.8,
p = 0.0003). In ELA, E2,RS was reduced in VV compared to VCV
(VV: 0.39 ± 0.20 vs. VCV: 0.81 ± 0.25, p = 0.021). The arterial
partial pressure of oxygen (PaO2) increased over time, with no
significant differences in arterial pH, arterial partial pressure of
carbon dioxide (PaCO2), or bicarbonate (HCO
−
3 ) between VCV
and VV in either group (SAL and ELA), as shown in Table 1.
In the ELA group, the fraction area of normal alveoli was
increased, while areas of alveolar collapse and hyperinflationwere
decreased in both VCV and VV compared to NV. The fraction
areas of alveolar collapse and hyperinflation were smaller in VV
than VCV (alveolar collapse: VV, 5.3 ± 2.6 vs. VCV, 11.2 ± 6.8,
p = 0.028; hyperinflation: VV, 3.5 ± 2.6 vs. VCV, 14.0 ± 7.6,
p = 0.0008). EELV was higher in ELA compared to SAL groups,
regardless of ventilation mode (Table 2).
In the SAL group, the PAT/PET ratio was higher in VV
compared to VCV (VV, 0.62 ± 0.12 vs. VCV, 0.42 ± 0.12;
p = 0.023), but in the ELA group, no differences were observed
between VV and VCV (Table 3). In the ELA group, RV area was
larger in VV than VCV (VV, 0.42 ± 0.07 vs. VCV, 0.31 ± 0.01;
p = 0.039).
In the SAL group, mRNA expressions of IL-6, amphiregulin,
and VEGF were higher in VCV compared to NV [IL-6: VCV,
140.5 (79.9–241.7) vs. NV, 0.64 (0.62–0.88), p = 0.004;
amphiregulin: VCV, 6.7 (4.8–15.7) vs. NV, 0.81 (0.36–1.38),
p = 0.012; VEGF: VCV, 6.53 (5.98–11.58) vs. NV, 0.95 (0.76–
1.25), p = 0.003], irrespective of mechanical ventilation mode
(Figure 3). In the ELA group, IL-6 expression was higher in
both VCV [31.46 (27.52–100.9)] and VV [40.93 (25.37–66.95)]
compared to NV [0.47 (0.21–1.74), p = 0.021 and p = 0.013
Frontiers in Physiology | www.frontiersin.org 5 June 2016 | Volume 7 | Article 277
Henriques et al. Variable Ventilation in Elastase-Induced Emphysema
FIGURE 1 | Characterization of elastase-induced emphysema model in rats. Data are presented as means + standard deviation (SD) or as box plots of
median and interquartile range (whiskers indicate the 10th and 90th percentiles), and refer to 7 rats in each ELA group and 28 rats in the SAL group. EELV,
end-expiratory lung volume; EL,spec, specific lung elastance; Lm, mean linear intercept between alveolar walls; hyperinflation, fraction area of hyperinflated areas;
Elastic Fibers, fraction area of elastic fibers; Collagen Fibers, fraction area of collagen fibers; PAT/PET, ratio between pulmonary artery systolic acceleration time (PAT)
and pulmonary artery systolic ejection time (PET) on pulsed-wave doppler (A.U.); RV Area, right ventricular end-diastolic area (mm2). *Significantly different from SAL
group (p < 0.0125). #Significantly different from ELA at 1 week (p < 0.0125).
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FIGURE 2 | Real-time polymerase chain reaction analysis of biological markers associated with inflammation (interleukin [IL]-6, cytokine-induced
neutrophil chemoattractant [CINC]-1), alveolar stretch (amphiregulin), type II epithelial cell mechanotransduction (surfactant protein [SP]-D), and
endothelial cell damage (angiopoietin [Ang]-2, vascular endothelial growth factor [VEGF]). SAL: animals that received saline and were analyzed 5 weeks
after the last saline endotracheal instillation; ELA: animals that received elastase and were analyzed 5 weeks after the last elastase endotracheal instillation. Data are
presented as box plots of median and interquartile range (whiskers indicate the 10th and 90th percentiles), and refer to seven animals in the SAL and ELA groups.
Relative gene expression was calculated as a ratio of the average gene expression levels compared with the reference gene (36B4) and expressed as fold change
relative to SAL. *Significantly different from SAL group (p < 0.05).
respectively]. VV animals exhibited increased SP-D expression
compared to NV animals (Figure 3) [VV, 2.44 (2.21–2.82) vs. NV,
0.84 (0.32–1.46), p = 0.008].
DISCUSSION
In the first protocol, biological markers associated with
inflammation, alveolar stretch, and damage inflicted to alveolar
endothelial cells were increased at the time point of greatest
cardiorespiratory impairment [high specific lung elastance
and large right ventricular end-diastolic area (5 weeks after
the last elastase endotracheal instillation)], thus characterizing
a successful model of elastase-induced emphysema. In the
second protocol, variable ventilation (compared to conventional
volume-controlled ventilation) reduced respiratory system
elastance, lung hyperinflation, and alveolar collapse, and
Frontiers in Physiology | www.frontiersin.org 7 June 2016 | Volume 7 | Article 277
Henriques et al. Variable Ventilation in Elastase-Induced Emphysema
TABLE 1 | Respiratory and blood gas exchange parameters at Baseline PEEP and End.
SAL ELA
VCV VV VCV VV
VT
(mL/kg)
Baseline PEEP 6.0± 0.0 6.0± 0.0 6.0±0.0 6.0±0.0
End 6.0± 0.1 6.1± 0.1 6.0±0.0 6.1±0.1
CV of VT
(%)
Baseline PEEP 2.0± 0.3 2.0± 0.2 2.1±0.4 2.0±0.3
End 2.1± 0.4 28.2± 0.6#,& 2.2±0.9 28.0±2.1‡,&
V’E
(mL/min)
Baseline PEEP 147.8± 4.6 145.5± 6.1 144.5±3.5 148.9±1.9
End 146.2± 12.1 145.6± 5.3 144.7±9.6 149.3±7.5
E,RS
(cmH2O/mL)
Baseline PEEP 3.3± 0.4 3.5± 0.3 3.7±0.8 3.5±0.7
End 3.6± 0.1 2.3± 0.4#,& 3.6±0.8 2.5±0.4‡,&
E1,RS
(cmH2O/mL)
Baseline PEEP 3.0± 0.7 2.7± 0.4 2.5±0.5 2.4±0.5
End 3.3± 1.1 2.4± 0.6& 2.7±0.6 2.2±0.5
E2,RS
(cmH2O/mL)
Baseline PEEP 0.32± 0.38 0.48± 0.21 0.71±0.21 0.76±0.42
End 0.43± 0.39 0.19± 0.13& 0.81±0.25 0.39±0.20‡,&
%E2 Baseline PEEP 29.8± 37.6 48.9± 16.4 62.3±7.8 62.1±14.8
End 36.9± 37.1 32.4± 19.1& 63.1±11.0 49.4±19.3&
R
(cmH2O/mL/s)
Baseline PEEP 0.22± 0.11 0.24± 0.11 0.27±0.13 0.20±0.07
End 0.22± 0.11 0.20± 0.10 0.23±0.09 0.21±0.10
PEEP
(cmH2O)
Baseline PEEP 3.0± 0.1 3.1± 0.1 3.0±0.1 3.1±0.1
End 3.0± 0.1 3.1± 0.1 3.0±0.2 3.1±0.1
PEEPi
(cmH2O)
Baseline PEEP 0.4± 0.1 0.5± 0.5 0.5±0.2 0.4±0.1
End 0.4± 0.1 0.4± 0.1 0.4±0.1 0.4±0.1
pHa Baseline PEEP 7.4± 0.0 7.4± 0.0 7.4±0.1 7.4±0.1
End 7.4± 0.1 7.4± 0.0 7.3±0.1 7.4±0.1
PaO2
(mmHg)
Baseline PEEP 108± 27 125± 28 111±31 121±22
End 166± 48& 191± 51& 161±51& 199±34&
PaCO2
(mmHg)
Baseline PEEP 37.6± 4.1 34.5± 6.7 35.2±9.3 37.5±10.3
End 35.0± 6.8 35.1± 2.6 40.1±7.1 33.9±9.0
HCO3
(mEq/L)
Baseline PEEP 23.6± 1.6 23.2± 2.3 21.8±4.3 22.6±2.3
End 22.4± 2.9 22.6± 1.9 22.0±2.0 20.1±2.7
Values are mean ± standard deviation (SD) of eight animals in each group. SAL: animals that received saline and were analyzed 5 weeks after the last saline endotracheal instillation;
ELA: animals that received elastase and were analyzed 5 weeks after the last elastase endotracheal instillation; VCV: volume-controlled ventilation; VV: variable ventilation; VT : tidal
volume; CV of VT : coefficient of variation of tidal volume; V’E : minute ventilation; E,RS: dynamic respiratory system elastance; E1,RS: volume-independent elastance; E2,RS: volume-
dependent elastance; %E2: E,RS non-linearity index; R: airway resistance; PEEP: positive end-expiratory pressure; PEEPi: intrinsic positive end-expiratory pressure; pHa: arterial pH;
PaCO2: arterial carbon dioxide partial pressure; PaO2: arterial oxygen partial pressure; HCO3: bicarbonate. Comparisons were performed by two-way repeated-measures ANOVA
followed by Bonferroni’s post-hoc test (p < 0.05). Paired t-tests were used to compare Baseline PEEP and End. #Significantly different from SAL-VCV (p < 0.05). ‡Significantly different
from ELA-VCV (p < 0.05). &Significantly different from Baseline PEEP (p < 0.05).
augmented surfactant protein-D expression; however, it also
increased right ventricular end-diastolic area.
First Protocol: Characterization of
Elastase-Induced Emphysema in Rats
In the model of elastase induced-emphysema used herein,
lung mechanics, morphology, fibrogenesis, and elastolysis were
altered at different time points. At 5 weeks, most of these
changes were associated with lower ratio between PAT and
PET, enlarged right ventricular end-diastolic area, and increased
mRNA expression of interleukin-6, cytokine-induced neutrophil
chemoattractant, amphiregulin, angiopoietin-2, and vascular
endothelial growth factor compared to SAL. In addition,
according to CT measurements, ELA animals showed lung
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TABLE 2 | Lung morphometry in mechanically ventilated animals.
SAL ELA
NV VCV VV NV VCV VV
Normal (%) 87.6±13.4 89.4±6.9 95.9± 3.2# 55.6± 4.9* 74.8±9.2**,# 91.2±3.1**,‡
Collapse (%) 5.3±3.9 5.9±5.3 4.0± 3.2 4.7± 1.7 11.2±6.8** 5.3±2.6‡
Hyperinflation (%) 2.5±7.0 4.7±5.1 0.0± 0.0 39.7± 4.9* 14.0±7.6**,# 3.5±2.6**,‡
Lm (µ m) 48.2±8.8 64.2±23.4 69.6± 18.9 66.3± 10.8* 104.9±17.1**,# 97.6±16.7**,†
EELV (mL) 3.2±0.8 2.4±0.5 2.6± 0.8 4.6± 1.2* 3.7±0.9# 3.7±1.2†
Values are mean ± standard deviation (SD) of eight animals in each group. SAL: animals that received saline and were analyzed 5 weeks after the last instillation; ELA: animals that
received elastase and were analyzed 5 weeks after the last elastase endotracheal instillation; NV: non-ventilated; VCV: volume-controlled ventilation; VV: variable ventilation. Normal:
normal fraction area as percentage; Collapse: collapsed fraction area as percentage; Hyperinflation: hyperinflated fraction area as percentage; Lm: mean linear intercept; EELV: End-
expiratory lung volume. Comparisons were performed by two-way repeated-measures ANOVA followed by Bonferroni’s post-hoc test (p < 0.05). *Significantly different from SAL-NV (p
< 0.05). **Significantly different from ELA-NV (p < 0.05). #Significantly different from SAL-VCV (p < 0.05). ‡Significantly different from ELA-VCV (p < 0.05).
†
Significantly different from
SAL-VV (p < 0.05).
attenuation coefficients similar to those observed in other models
of elastase-induced pulmonary emphysema (Onclinx et al., 2006)
and in human emphysema, with lung CT voxels exhibiting
attenuation values in the region of −950 HU (low attenuation
areas) (Bhavani et al., 2015). Our model differs from several
others of elastase-induced emphysema due to animal strain
(Onclinx et al., 2006; Schmiedl et al., 2008; Tolnai et al., 2012;
Kawago et al., 2014) and elastase dose and regimen (Onclinx
et al., 2006; Schmiedl et al., 2008; Di Petta et al., 2011; Tolnai
et al., 2012); most use a single dose (Schmiedl et al., 2008; Di Petta
et al., 2011; Tolnai et al., 2012), involve evaluation at only one
time point, and do not focus on the extrapulmonary impairment
which is usually present in severe human emphysema. Yokoyama
et al. (1987) found morphological changes characteristic of
emphysematous lesions 7–10 weeks after single intratracheal
administration of elastase (6.5 units) in rats. Furthermore, recent
studies in mice (Cruz et al., 2012; Antunes et al., 2014) reported
that multiple elastase instillations can lead to cardiorespiratory
alterations.
Second Protocol: Comparison between
Variable and Conventional
Volume-Controlled Ventilation
Previous experimental studies (Spieth et al., 2009b;
Thammanomai et al., 2013) have shown that VV improves
gas exchange and respiratory mechanics, as well as reduces lung
damage and inflammation in experimental ARDS. To the best of
our knowledge, the present study was the first to investigate the
effects of VV and VCV on lung morphofunction and biological
markers associated with VILI in experimental emphysema. To
minimize the potential effects of VV and VCV, a protective tidal
volume was used during both strategies.
Respiratory System Mechanics and Lung Histology
The fact that VV, but not VCV, decreased dynamic respiratory
system elastance and non-linearity index of the dynamic
respiratory system elastance over time is likely explained by lung
recruitment (Kano et al., 1994; Bersten, 1998). Alveolar collapse
and hyperinflation were lower in VV compared to VCV, which
may have led to better distribution of regional ventilation and of
stress and strain across the lungs. Our observation that VV did
not improve gas exchange compared to VCV might be explained
by differences in regional perfusion (Pelosi and de Abreu, 2015).
Variable ventilation reduced alveolar collapse and
hyperinflation only in ELA thus resulting in decreased dynamic
respiratory system elastance and volume-dependent elastance.
We hypothesize that VV promoted alveolar recruitment by
periodic higher inspiratory pressures, reducing the traction
of alveolar walls by collapsed regions and thus mitigating
hyperinflation. In short, VV resulted in better distribution of
regional ventilation, stress, and strain across the lungs.
Cardiac Impairment
In SAL animals, after VV, the fraction area of normal alveoli
increased, thus resulting in a reduction of pulmonary vascular
resistance, as shown by the increase in the ratio between
pulmonary artery systolic acceleration time and pulmonary
artery systolic ejection time. This is expected in a normal
capillary density scenario (Overholser et al., 1994); however,
similar behavior was not observed in ELA animals. After VV,
even though the fraction area of normal alveoli increased,
pulmonary vascular resistance may have increased as well,
thus leading to enlargement of right ventricular end-diastolic
area. The relationship between pulmonary vascular resistance
and lung volume is “U-shaped,” where the lowest pulmonary
vascular resistance values are closer to functional residual
capacity (Simmons et al., 1961). In elastase-induced emphysema,
arterial remodeling occurs, with increased elastolysis in the
vessel wall (Wills et al., 1996). Furthermore, hyperinflated
and collapsed alveoli may not receive adequate blood flow,
due to vascular compression and hypoxic vasoconstriction,
respectively; thus, blood flow could be driven toward normal
alveoli. After VV, there was likely a better airflow distribution
across the airways, which may have led to improved lung
volume distribution, since there was no change in total lung
volume as detected by EELV measurements. We hypothesized
that, after lung volume redistribution, a reduction in alveolar
hyperinflation and recruitment of alveolar collapse occurred,
alongside a slight decrease in size of normal alveoli, resulting in
increased pulmonary vascular resistance, as indirectly measured
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TABLE 3 | Echocardiography data at Baseline PEEP and End.
SAL ELA
VCV VV VCV VV
RV area
(mm2 )
Baseline
PEEP
0.25± 0.04 0.25± 0.07 0.38±0.07# 0.39± 0.08†
End 0.34± 0.14 0.28± 0.05 0.31±0.01 0.42± 0.07‡,†
PAT/PET Baseline
PEEP
0.51± 0.05 0.51± 0.07 0.41±0.04# 0.42± 0.04†
End 0.42± 0.12 0.62± 0.12#,& 0.44±0.09 0.37± 0.09†
LV area
(mm2 )
Baseline
PEEP
0.17± 0.04 0.14± 0.07 0.18±0.02 0.17± 0.08
End 0.19± 0.09 0.16± 0.06 0.19±0.03 0.21± 0.07
EF (%) Baseline
PEEP
91.3± 2.7 94.3± 4.7 93.2±5.2 90.3± 6.8
End 90.2± 4.6 92.0± 4.3 89.2±4.6 91.6± 2.2
FS (%) Baseline
PEEP
57.9± 4.0 66.0± 11.5 62.3±9.0 57.8± 10.5
End 56.8± 7.0 59.6± 7.2 52.5±7.1 58.2± 3.6
HR (bpm) Baseline
PEEP
387± 43 404± 39 439±30 386± 42
End 388± 41 411± 31 410±53 375± 51
IVC
diameter
(mm)
Baseline
PEEP
0.22± 0.04 0.23± 0.07 0.20±0.04 0.18± 0.03
End 0.22± 0.03 0.26± 0.03 0.22±0.06 0.27± 0.03&
RA
diameter
(mm)
Baseline
PEEP
0.42± 0.06 0.46± 0.05 0.42±0.05 0.42± 0.08
End 0.48± 0.10 0.47± 0.12 0.44±0.09 0.52± 0.11
Values are mean ± standard deviation (SD) of eight animals in each group. SAL:
animals that received saline and were analyzed 5 weeks after the last instillation; ELA:
animals that received elastase and were analyzed 5 weeks after the last elastase
endotracheal instillation; VCV: volume-controlled ventilation; VV: variable ventilation; RV
area: right ventricular end-diastolic area; PAT/PET: relation between pulmonary artery
systolic acceleration time (PAT) and pulmonary artery systolic ejection time (PET) on
pulsed-wave Doppler; LV: left ventricular end-diastolic area; EF: ejection fraction; FS:
fractional shortening; HR: heart rate; IVC: inferior vena cava; RA: right atrium. Comparisons
were performed by two-way repeated-measures ANOVA followed by Bonferroni’s post-
hoc test (p < 0.05). Paired t-tests were done to compare Baseline PEEP and End.
#Significantly different from SAL-VCV (p < 0.05).
†
Significantly different from SAL-VV (p
< 0.05). ‡Significantly different from ELA-VCV (p < 0.05). &Significantly different from
Baseline PEEP (p < 0.05).
by echocardiographic analysis (ratio between pulmonary artery
systolic acceleration time and pulmonary artery systolic ejection
time, and right ventricular end-diastolic area). This effect can
move the point from the lowest pulmonary vascular resistance
at functional residual capacity to the right side of the curve,
thus increasing the pulmonary vascular resistance by alveolar
vessel distortion. Additionally, during VV, the higher frequency
of increased tidal volume and plateau pressure in a fixed time
course may lead to increased pulmonary vascular resistance,
especially in the presence of vessel wall changes.
Biological Markers
In SAL animals, VCV, but not VV, led to increased mRNA
expression of interleukin-6, amphiregulin, and vascular
endothelial growth factor compared to NV. In this line, an
in vitro study reported that exposure of normal cultured
epithelial cells to increased stress and strain results in cell
membrane disruption and death (Tschumperlin and Margulies,
1999). In non-injured lungs, VV reduced stress and strain,
preventing inflammation, alveolar stretch, and endothelial
damage. In ELA, no difference was observed between VV and
VCV regarding interleukin-6 mRNA expression, suggesting
that mechanical ventilation per se induces activation of lung
inflammation. In the emphysematous lung, which tends to
be more structurally fragile (Suki et al., 2013), moderate and
high tidal volumes (based on the normal distribution with a
30% coefficient of variation) during VV could increase lung
inflammation. On the other hand, VV resulted in beneficial
biological effects through an increase in surfactant protein-D
expression, which is in agreement with previous experimental
findings in experimental ARDS (Thammanomai et al., 2013).
We may speculate that application of variable stretch to alveolar
epithelial cells led to mechanotransduction toward intracellular
signaling and cytoplasmic reorganization in an attempt to restore
surfactant production (Roan and Waters, 2011).
LIMITATIONS
This study has several limitations which must be taken
into account. First, emphysema was induced by intratracheal
administration of elastase, and our results cannot be extended
to other emphysema models with different degrees of severity,
nor to human emphysema. Second, the PEEP levels used
in the current study, while often used in rats, may not be
directly extrapolated to the clinical setting. Third, the coefficient
of variation of tidal volume was based on existing acute
lung injury models (Spieth et al., 2009a) that showed 30%
as the best compromise between lung mechanics and blood
gas exchange, since no study of VV in emphysema has been
conducted. This degree of variation resulted in additional right
ventricular load. Thus, future studies evaluating different tidal
volume coefficients of variation in experimental emphysema are
warranted. Fourth, echocardiographic images were not gated
to respiratory period or tidal volume, which may have affected
cardiac parameter measurements. However, echocardiographic
images were collected during 15min at each time point, which
may have minimized potential bias. Finally, mediators were
measured in lung tissue, but not in blood, and the observation
time was relatively short, thus precluding assessment of potential
changes in protein levels of all biological markers of interest;
keeping animals with emphysema hemodynamically stable for
more than 6 h to measure actual protein levels would have
required administration of greater amounts of fluids, which
could have interfered with gene expression. Even though no
emphysema model is able to reproduce all features of human
emphysema, the rat model of elastase-induced emphysema
used in this study induces lung morphological changes that
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FIGURE 3 | Real-time polymerase chain reaction analysis of biological markers associated with inflammation [interleukin (IL)-6], alveolar stretch
(amphiregulin), type II epithelial cell mechanotransduction [surfactant protein (SP)-D], and endothelial injury [vascular endothelial growth factor
(VEGF)]. SAL: animals that received saline and were analyzed 5 weeks after the last saline endotracheal instillation; ELA: animals that received elastase and were
analyzed 5 weeks after the last elastase endotracheal instillation. Data are presented as box plots of median and interquartile range (whiskers indicate the 10th and
90th percentiles), and refer to eight animals in the SAL and ELA groups. Relative gene expression was calculated as the ratio of average gene expression compared
with the reference gene (36B4) and expressed as fold change relative to SAL-NV or ELA-NV, as appropriate. *Significantly different from SAL-NV group (p < 0.05).
**Significantly different from ELA-NV group (p < 0.05).
may provide a more efficient tool to better understand the
cardiorespiratory effects after mechanical ventilation, with
potential for translation into clinical practice. This is a first step
toward understanding the mechanism of VILI in emphysema.
In conclusion, compared to VCV, VV improved lung
mechanics and histology as well as augmented surfactant protein-
D gene expression, but increased right ventricular end-diastolic
area in a rat model of elastase induced-emphysema.
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